New research reveals that popular weight-loss drugs might do more than help people shed pounds – they could reduce the risk of obesity-related cancers by 41%. A breakthrough study of 6,000 adults found that first-generation weight-loss injections like Saxenda, Byetta, and Trulicity worked just as well as weight-loss surgery in preventing cancer, despite patients losing less weight with the medications. “We found these medications to be 41% more effective at preventing obesity-related cancer,” says Dr. Yael Wolff Sagy from Clalit Health Services in Tel-Aviv. “The benefits go beyond just losing weight.” The medications, known as GLP-1 receptor agonists, showed impressive … Continue reading GLP-1 Drugs Cut Obesity-Linked Cancer Risk by 41%, Surpassing Surgery